Brief: Acucort Obtains Regulatory Approval To Start Bioequivalence Study For The EU
04/10/2018 14:41
AcuCort AB ACUC.TE :
* ACUCORT OBTAINS REGULATORY APPROVAL TO START
BIOEQUIVALENCE
STUDY FOR THE EU
* CZECH STATE INSTITUTE FOR DRUG CONTROL, SUKL APPROVED CO'S
APPLICATION TO CONDUCT BIOEQUIVALENCE STUDY
Source text for Eikon: ID:nWkr5SjHz8
Further company coverage: ACUC.TE
Recent news on AcuCort AB
See all newsBrief: Acucort Plans To Apply For U.S. Market Approval For Zeqmelit In 2026
Brief: AcuCort Signs Its First Commercial Agreement For Zeqmelit
Brief: Acucort AB Acucort Receives Marketing Authorization For Drug Zeqmelit By Norwegian Medicines Agency
Brief: Acucort Receives Marketing Authorization For The Drug Zeqmelit By The Danish Medicines Agency
Brief: AcuCort Is Granted Sme Status By The European Medicines Agency, EMA